208 related articles for article (PubMed ID: 34632328)
1. Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease.
Warner BM; Santry LA; Leacy A; Chan M; Pham PH; Vendramelli R; Pei Y; Tailor N; Valcourt E; Leung A; He S; Griffin BD; Audet J; Willman M; Tierney K; Albietz A; Frost KL; Yates JGE; Mould RC; Chan L; Mehrani Y; Knapp JP; Minott JA; Banadyga L; Safronetz D; Wood H; Booth S; Major PP; Bridle BW; Susta L; Kobasa D; Wootton SK
iScience; 2021 Nov; 24(11):103219. PubMed ID: 34632328
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2.
Park JG; Oladunni FS; Rohaim MA; Whittingham-Dowd J; Tollitt J; Hodges MDJ; Fathallah N; Assas MB; Alhazmi W; Almilaibary A; Iqbal M; Chang P; Escalona R; Shivanna V; Torrelles JB; Worthington JJ; Jackson-Jones LH; Martinez-Sobrido L; Munir M
iScience; 2021 Sep; 24(9):102941. PubMed ID: 34368648
[TBL] [Abstract][Full Text] [Related]
3. Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges.
Warner BM; Yates JGE; Vendramelli R; Truong T; Meilleur C; Chan L; Leacy A; Pham PH; Pei Y; Susta L; Wootton SK; Kobasa D
NPJ Vaccines; 2024 May; 9(1):90. PubMed ID: 38782986
[TBL] [Abstract][Full Text] [Related]
4. Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental challenge infection in hamsters.
de Swart RL; de Leeuw OS; Oreshkova N; Gerhards NM; Albulescu IC; Vreman S; Gonzales JL; Maas R; van Kuppeveld FJM; Soema P; Bosch BJ; Peeters BPH
Vaccine; 2022 Aug; 40(33):4676-4681. PubMed ID: 35820941
[TBL] [Abstract][Full Text] [Related]
5. Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate.
Sun W; Leist SR; McCroskery S; Liu Y; Slamanig S; Oliva J; Amanat F; Schäfer A; Dinnon KH; García-Sastre A; Krammer F; Baric RS; Palese P
bioRxiv; 2020 Jul; ():. PubMed ID: 32743571
[TBL] [Abstract][Full Text] [Related]
6. Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats.
Tcheou J; Raskin A; Singh G; Kawabata H; Bielak D; Sun W; González-Domínguez I; Sather DN; García-Sastre A; Palese P; Krammer F; Carreño JM
Front Immunol; 2021; 12():791764. PubMed ID: 34868082
[TBL] [Abstract][Full Text] [Related]
7. Newcastle Disease Virus (NDV)-based vaccine candidate against SARS-CoV-2 Omicron by intranasal immunization.
Zhang QY; Zhang HQ; Zhang YN; Zhang ZR; Li XD; Hao MC; Zhang Y; Li JQ; Hu YY; Chen XL; Wang J; Shi YJ; Deng CL; Chen JJ; Ye HQ; Zhang B
Antiviral Res; 2023 Dec; 220():105757. PubMed ID: 37984567
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam.
Duc Dang A; Dinh Vu T; Hai Vu H; Thanh Ta V; Thi Van Pham A; Thi Ngoc Dang M; Van Le B; Huu Duong T; Van Nguyen D; Lawpoolsri S; Chinwangso P; McLellan JS; Hsieh CL; Garcia-Sastre A; Palese P; Sun W; Martinez JL; Gonzalez-Dominguez I; Slamanig S; Manuel Carreño J; Tcheou J; Krammer F; Raskin A; Minh Vu H; Cong Tran T; Mai Nguyen H; Mercer LD; Raghunandan R; Lal M; White JA; Hjorth R; Innis BL; Scharf R
Vaccine; 2022 Jun; 40(26):3621-3632. PubMed ID: 35577631
[TBL] [Abstract][Full Text] [Related]
9. A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters.
Lu M; Zhang Y; Dravid P; Li A; Zeng C; Kc M; Trivedi S; Sharma H; Chaiwatpongsakorn S; Zani A; Kenney A; Cai C; Ye C; Liang X; Qiu J; Martinez-Sobrido L; Yount JS; Boyaka PN; Liu SL; Peeples ME; Kapoor A; Li J
J Virol; 2021 Sep; 95(20):e0059221. PubMed ID: 34379509
[TBL] [Abstract][Full Text] [Related]
10. Intramuscular administration of recombinant Newcastle disease virus expressing SARS-CoV-2 spike protein protects hACE-2 TG mice against SARS-CoV-2 infection.
Kim DH; Lee J; Youk S; Jeong JH; Lee DY; Ju HS; Youn HN; Kim JC; Park SB; Park JE; Kim JY; Kim TH; Lee SH; Lee H; Mouhamed Abdallah Amal Abdal L; Lee DH; Park PG; Hong KJ; Song CS
Vaccine; 2023 Jul; 41(33):4787-4797. PubMed ID: 37355454
[TBL] [Abstract][Full Text] [Related]
11. Mucosal Vaccination with a Newcastle Disease Virus-Vectored Vaccine Reduces Viral Loads in SARS-CoV-2-Infected Cynomolgus Macaques.
Warner BM; Chan M; Tailor N; Vendramelli R; Audet J; Meilleur C; Truong T; Garnett L; Willman M; Soule G; Tierney K; Albietz A; Moffat E; Higgins R; Santry LA; Leacy A; Pham PH; Yates JGE; Pei Y; Safronetz D; Strong JE; Susta L; Embury-Hyatt C; Wootton SK; Kobasa D
Vaccines (Basel); 2024 Apr; 12(4):. PubMed ID: 38675786
[TBL] [Abstract][Full Text] [Related]
12. A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters.
Bricker TL; Darling TL; Hassan AO; Harastani HH; Soung A; Jiang X; Dai YN; Zhao H; Adams LJ; Holtzman MJ; Bailey AL; Case JB; Fremont DH; Klein R; Diamond MS; Boon ACM
Cell Rep; 2021 Jul; 36(3):109400. PubMed ID: 34245672
[TBL] [Abstract][Full Text] [Related]
13. Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice.
González-Domínguez I; Martínez JL; Slamanig S; Lemus N; Liu Y; Lai TY; Carreño JM; Singh G; Singh G; Schotsaert M; Mena I; McCroskery S; Coughlan L; Krammer F; García-Sastre A; Palese P; Sun W
Microbiol Spectr; 2022 Jun; 10(3):e0153822. PubMed ID: 35658571
[TBL] [Abstract][Full Text] [Related]
14. A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters.
Liu X; Luongo C; Matsuoka Y; Park HS; Santos C; Yang L; Moore IN; Afroz S; Johnson RF; Lafont BAP; Martens C; Best SM; Munster VJ; Hollý J; Yewdell JW; Le Nouën C; Munir S; Buchholz UJ
Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34876520
[TBL] [Abstract][Full Text] [Related]
15. A single intranasal dose of human parainfluenza virus type 3-vectored vaccine induces effective antibody and memory T cell response in the lungs and protects hamsters against SARS-CoV-2.
Ilinykh PA; Periasamy S; Huang K; Kuzmina NA; Ramanathan P; Meyer MN; Mire CE; Kuzmin IV; Bharaj P; Endsley JR; Chikina M; Sealfon SC; Widen SG; Endsley MA; Bukreyev A
NPJ Vaccines; 2022 Apr; 7(1):47. PubMed ID: 35468973
[TBL] [Abstract][Full Text] [Related]
16. Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens.
DiNapoli JM; Kotelkin A; Yang L; Elankumaran S; Murphy BR; Samal SK; Collins PL; Bukreyev A
Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9788-93. PubMed ID: 17535926
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Parainfluenza Virus 5 (PIV5)-vectored Intranasal COVID-19 Vaccine as a Single Dose Vaccine and as a Booster against SARS-CoV-2 Variants.
Beavis AC; Li Z; Briggs K; Huertas-Díaz MC; Wrobel ER; Najera M; An D; Orr-Burks N; Murray J; Patil P; Huang J; Mousa J; Hao L; Hsiang TY; Gale M; Harvey SB; Tompkins SM; Hogan RJ; Lafontaine ER; Jin H; He B
bioRxiv; 2022 Jun; ():. PubMed ID: 35702147
[TBL] [Abstract][Full Text] [Related]
18. Development of SARS-CoV-2 animal vaccines using a stable and efficient NDV expression system.
He L; Zhong J; Li G; Lin Z; Zhao P; Yang C; Wang H; Zhang Y; Yang X; Wang Z
J Med Virol; 2023 Jan; 95(1):e28237. PubMed ID: 36258299
[TBL] [Abstract][Full Text] [Related]
19. Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease.
Díaz MF; Calderón K; Rojas-Neyra A; Vakharia VN; Choque-Guevara R; Montalvan-Avalos A; Poma-Acevedo A; Rios-Matos D; Agurto-Arteaga A; Cauti-Mendoza MG; Perez-Martinez N; Isasi-Rivas G; Tataje-Lavanda L; Sernaque-Aguilar Y; Ygnacio F; Criollo-Orozco M; Huaccachi-Gonzalez E; Delgado-Ccancce E; Villanueva-Pérez D; Montesinos-Millán R; Gutiérrez-Manchay K; Pauyac-Antezana K; Ramirez-Ortiz I; Quiñones-Garcia S; Cauna-Orocollo Y; Vallejos-Sánchez K; Rios-Angulo A; Núñez-Fernández D; Salguedo-Bohorquez MI; Ticona J; Fernández-Sánchez M; Icochea E; Guevara-Sarmiento LA; Zimic M;
Sci Rep; 2022 Jun; 12(1):10359. PubMed ID: 35725862
[TBL] [Abstract][Full Text] [Related]
20. Oral Administration of Universal Bacterium-Vectored Nucleocapsid-Expressing COVID-19 Vaccine is Efficacious in Hamsters.
Jia Q; Bielefeldt-Ohmann H; Maison RM; Hartwig A; Masleša-Galić S; Bowen RA; Horwitz MA
Microbiol Spectr; 2023 Mar; 11(2):e0503522. PubMed ID: 36916971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
